Enhancing tristetraprolin activity reduces the severity of cigarette smoke-induced experimental chronic obstructive pulmonary disease

- Nair, Prema M., Starkey, Malcolm R., Haw, Tatt Jhong, Liu, Gang, Collison, Adam M., Mattes, Joerg, Wark, Peter A., Morris, Jonathan C., Verrills, Nikki M., Clark, Andrew R., Ammit, Alaina J., Hansbro, Philip M.

TRAIL signals through the ubiquitin ligase MID1 to promote pulmonary fibrosis

- Collison, Adam M., Li, Junyao, de Siqueira, Ana Pereira, Lv, Xuejiao, Toop, Hamish D., Morris, Jonathan C., Starkey, Malcolm R., Hansbro, Philip M., Zhang, Jie, Mattes, Joerg

Activating protein phosphatase 2A (PP2A) enhances tristetraprolin (TTP) anti-inflammatory function in A549 lung epithelial cells

- Rahman, Md. Mostafizur, Rumzhum, Nowshin N., Hansbro, Philip M., Morris, Jonathan C., Clark, Andrew R., Verrills, Nicole M., Ammit, Alaina J.

Activiating protein phosphatase 2A (PP2A) enhances tristetraprolin (TTP) anti-inflammatory function in A549 lung epithelial cells

- Rahman, Md. Mostafizur, Rumzhum, Nowshin N., Hasbro, Philip M., Morris, Jonathan C., Clark, Andrew R., Verrills, Nicole M., Ammit, Alaina J.

Development of novel PP2A activators for use in the treatment of acute myeloid leukaemia

- Toop, Hamish D., Dun, Matthew D., Ross, Bryony K., Flanagan, Hayley M., Verrills, Nicole M., Morris, Jonathan C.

The phosphorylated form of FTY720 activates PP2A, represses inflammation and is devoid of S1P agonism in A549 lung epithelial cells

- Rahman, Md. Mostafizur, Prũnte, Laura, Lebender, Leonard F., Patel, Brijeshkumar S., Gelissen, Ingrid, Hansbro, Philip M., Morris, Jonathan C., Clark, Andrew R., Verrills, Nicole M., Ammit, Alaina J.

Basal protein phosphatase 2A activity restrains cytokine expression: role for MAPKs and tristetraprolin

- Rahman, Md. Mostafizur, Rumzhum, Nowshin N., Morris, Jonathan C., Clark, Andrew R., Verrills, Nicole M., Ammit, Alaina J.

MicroRNA-9 regulates steroid-resistant airway hyperresponsiveness by reducing protein phosphatase 2A activity

- Li, Jing Jing, Tay, Hock L., Mattes, Joerg, Foster, Paul S., Yang, Ming, Maltby, Steven, Xiang, Yang, Eyers, Fiona, Hatchwell, Luke, Zhou, Hong, Toop, Hamish D., Morris, Jonathan C., Nair, Parameswaran

Salmeterol attenuates chemotactic responses in rhinovirus-induced exacerbation of allergic airways disease by modulating protein phosphatase 2A

- Hatchwell, Luke, Girkin, Jason, Mattes, Joerg, Dun, Matthew D., Morten, Matthew, Verrills, Nicole, Toop, Hamish D., Morris, Jonathan C., Johnson, Sebastian L., Foster, Paul S., Collison , Adam

Tumor necrosis factor-related apoptosis-inducing ligand regulates hallmark features of airways remodeling in allergic airways disease

- Collison, Adam, Li, Junyao, Pereira de Siqueira, Ana, Zhang, Jie, Toop, Hamish D., Morris, Jonathan C., Foster, Paul S., Mattes, Joerg

The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity

- Collison, Adam, Hatchwell, Luke, Verrills, Nicole, Wark, Peter A. B., Pereira De Siqueira, Ana, Tooze, Melinda, Carpenter, Helen, Don, Anthony S., Morris, Jonathan C., Zimmermann, Nives, Bartlett, Nathan W., Rothenberg, Marc E., Johnston, Sebastian L., Foster, Paul S., Mattes, Joerg